MedPath

Comparision of analgesic efficacy of bupivacaine drug with and without an additive named dexmedetomidine in intervention of pudendal block in pediatric participants undergoing perineal procedures.

Not yet recruiting
Conditions
Diseases of the genitourinary system,
Registration Number
CTRI/2025/06/088744
Lead Sponsor
Sri Ramachandra Institute of higher education and research
Brief Summary

Perioperative pain management in pediatric patients is essential for enhancing recovery and minimizing postoperative complications. Pudendal nerve block, a

regional anesthesia technique, is increasingly preferred for perineal surgeries as it provides targeted analgesia, reduces systemic opioid use, and minimizes complications associated with central neuraxial blocks, such as dural puncture, motor block, and urinary retention. Among local anesthetics, bupivacaine is widely used for its efficacy and prolonged action. However, the addition of adjuvants like

dexmedetomidine has shown promise in enhancing analgesia. in this study, we are comparing the efficacy of dexmeditomidine as an adjuvant to 0.25% bupivacaine.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
44
Inclusion Criteria

Age 6 months to 7 years ASA physical status I- II Scheduled to undergo elective perineal surgeries- circumcision, hypospadias, PUJ fulguration, chordee repair.

Exclusion Criteria

Parent refusal History of allergic reactions to local aesthetics Bleeding diathesis Rash or infection at the injection site Anatomical spinal abnormality Liver diseases.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Determine the effects of the intervention as duration of analgesia as first time to rescue analgesictimeline assessed at baseline, every 5minutes till 90 minutes intraoperatively and till 24 hours post operatively.
Secondary Outcome Measures
NameTimeMethod
success of blockQuality of recovery score

Trial Locations

Locations (1)

Sri ramachandra institute of higher education and research

🇮🇳

Chennai, TAMIL NADU, India

Sri ramachandra institute of higher education and research
🇮🇳Chennai, TAMIL NADU, India
NUNNA HANNAH MOUNIKA
Principal investigator
9493718157
c125hannah@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.